Trial Profile
Clinical Trials Insight: 700013451
Status:
Not yet recruiting
Phase of Trial:
Phase I
Latest Information Update: 20 Jun 2006
Price :
$35
*
At a glance
- Drugs INCB 13739 (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Incyte Corporation
- 20 Jun 2006 New trial record.